Literature DB >> 21211963

Lack of association of IL-10 gene polymorphisms with prostate cancer: evidence from 11,581 subjects.

Yan-Feng Zou1, Fang Wang, Xiao-Liang Feng, Yang-Hua Tian, Jin-Hui Tao, Fa-Ming Pan, Fen Huang.   

Abstract

Published data on the association between interleukin-10 (IL-10) gene polymorphisms and prostate cancer (PCa) are inconclusive. To derive a more precise estimation of the association, we conducted a meta-analysis. Data were collected from the following electronic databases: PubMed, Elsevier Science Direct, Excerpta Medica Database and Chinese Biomedical Literature Database, with the last report up to September 2010. The odds ratio (OR) and its 95% confidence interval (95%CI) were used to assess the strength of association. A total of 13 separate studies including 5503 cases and 6078 controls based on the search criteria were involved in this meta-analysis. Meta-analysis was performed for three IL-10 gene polymorphisms (rs1800896, rs1800871, and rs1800872). We found no association between IL-10 gene rs1800896 polymorphism and PCa in overall population (G versus A: OR=1.00, 95%CI=0.91-1.10, P=0.99; AG+GG versus AA: OR=1.18, 95%CI=0.97-1.43, P=0.10; GG versus AA+AG: OR=1.04, 95%CI=0.86-1.26, P=0.67). In subgroup analysis, similar results were found in Caucasian (G versus A: OR=0.99, 95%CI=0.84-1.18, P=0.92; AG+GG versus AA: OR=1.32, 95%CI=0.90-1.94, P=0.16; GG versus AA+AG: OR=1.07, 95%CI=0.89-1.28, P=0.48), and Asian (G versus A: OR=0.97, 95%CI=0.78-1.20, P=0.78; AG+GG versus AA: OR=1.07, 95%CI=0.79-1.45, P=0.65; GG versus AA+AG: OR=1.24, 95%CI=0.38-4.07, P=0.73) populations. We did not detect an association between IL-10 gene rs1800871 polymorphism and PCa in overall population (T versus C: OR=0.96, 95%CI=0.85-1.08, P=0.51; CT+TT versus CC: OR=0.94, 95%CI=0.80-1.11, P=0.48; TT versus CC+CT: OR=0.94, 95%CI=0.81-1.10, P=0.44). Similar results were found in Asian population (T versus C: OR=0.85, 95%CI=0.71-1.09, P=0.09; CT+TT versus CC: OR=0.72, 95%CI=0.52-1.17, P=0.05; TT versus CC+CT: OR=0.89, 95%CI=0.68-1.17, P=0.39). We found no association between IL-10 gene rs1800872 polymorphism and PCa in overall population (A versus C: OR=1.03, 95%CI=0.96-1.11, P=0.41; CA+AA versus CC: OR=1.04, 95%CI=0.92-1.17, P=0.56; AA versus CC+CA: OR=1.02, 95%CI=0.85-1.22, P=0.87). Similar results were found in Caucasian population (A versus C: OR=1.06, 95%CI=0.98-1.16, P=0.16; CA+AA versus CC: OR=1.07, 95%CI=0.85-1.35, P=0.57; AA versus CC+CA: OR=1.23, 95%CI=0.92-1.64, P=0.17). This meta-analysis suggests that there is no association between IL-10 gene rs1800896, rs1800871 and rs1800872 polymorphisms and PCa.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21211963     DOI: 10.1016/j.ejca.2010.11.034

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  10 in total

1.  Association of interleukin-10-1082 promoter polymorphism with gastric cancer: appraisal of a recent meta-analysis.

Authors:  Fang Wang; Guoping Sun; Yanfeng Zou
Journal:  DNA Cell Biol       Date:  2012-05       Impact factor: 3.311

2.  Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.

Authors:  Danyelle A Winchester; Cathee Till; Phyllis J Goodman; Catherine M Tangen; Regina M Santella; Teresa L Johnson-Pais; Robin J Leach; Jianfeng Xu; S Lilly Zheng; Ian M Thompson; M Scott Lucia; Scott M Lippmann; Howard L Parnes; Paul J Dluzniewski; William B Isaacs; Angelo M De Marzo; Charles G Drake; Elizabeth A Platz
Journal:  Prostate       Date:  2015-06-05       Impact factor: 4.104

Review 3.  Gene variants in the angiogenesis pathway and prostate cancer.

Authors:  Ernest K Amankwah; Thomas A Sellers; Jong Y Park
Journal:  Carcinogenesis       Date:  2012-04-20       Impact factor: 4.944

4.  Association of SNPs/haplotypes in promoter of TNF A and IL-10 gene together with life style factors in prostate cancer progression in Indian population.

Authors:  Kapil Bandil; Pallavi Singhal; Atika Dogra; Sudhir K Rawal; D C Doval; Anil K Varshney; Mausumi Bharadwaj
Journal:  Inflamm Res       Date:  2017-10-09       Impact factor: 4.575

Review 5.  The interleukin 10 -819C/T polymorphism and cancer risk: a HuGE review and meta-analysis of 73 studies including 15,942 cases and 22,336 controls.

Authors:  Zhibin Yu; Qing Liu; Chen Huang; Minghua Wu; Guiyuan Li
Journal:  OMICS       Date:  2013-04

6.  The impact of interleukin-10 (IL-10) gene 4 polymorphisms on peripheral blood IL-10 variation and prostate cancer risk based on published studies.

Authors:  Tingting Men; Cuicui Yu; Dan Wang; Fang Liu; Jingjing Li; Xiaoying Qi; Chunhua Yang; Wenguo Jiang; Xiaodan Wei; Xuri Li; Bin Wang; Jia Mi; Geng Tian
Journal:  Oncotarget       Date:  2017-07-11

7.  Synthetic analysis of associations between IL-10 polymorphisms and skin cancer risk.

Authors:  Hongbo Zhao; Jiaoli Yang; Zhenzhen Yu; Hui Shen; Xinlin Huang; Mi Zhang; Teng Long; A Cailing; Wenhui Wang
Journal:  Oncotarget       Date:  2017-12-17

8.  Interleukin 10 gene rs1800896 polymorphism is associated with the risk of prostate cancer.

Authors:  Hao Chen; Jilei Tang; Nan Shen; Kewei Ren
Journal:  Oncotarget       Date:  2017-08-03

9.  Different Trends in the Incidence and Mortality Rates of Prostate Cancer Between China and the USA: A Joinpoint and Age-Period-Cohort Analysis.

Authors:  Hairong He; Liang Liang; Didi Han; Fengshuo Xu; Jun Lyu
Journal:  Front Med (Lausanne)       Date:  2022-02-03

10.  The single nucleotide polymorphisms of interleukin-10 are associated with the risk of leukaemia: Evidence from 18 case-control studies.

Authors:  Shupei Gao; Kun Tang; Jinqing Chen; Jianmiao Wang
Journal:  Medicine (Baltimore)       Date:  2020-10-30       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.